Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
1(11%)
Results Posted
25%(1 trials)
Terminated
3(33%)

Phase Distribution

Ph phase_3
1
11%
Ph phase_4
2
22%
Ph not_applicable
6
67%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

4 of 8 finished

Non-Completion Rate

50.0%

4 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(4)
Terminated(4)

Detailed Status

Completed4
Terminated3
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
57.1%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (11.1%)
Phase 42 (22.2%)
N/A6 (66.7%)

Trials by Status

completed444%
active_not_recruiting111%
withdrawn111%
terminated333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9